In the first comprehensive trial of its kind, a study from Medtronic, Inc. showed that its advanced insulin pump can safely shut itself off when blood sugar gets too low – adjusting insulin delivery accordingly without patient intervention.
Type 1 diabetes patients on long-term, intensive therapy are more likely to achieve near-normal levels of blood glucose, as well as a significantly lower risk of developing heart disease, stroke, kidney problems and severe eye disease
Medtronic Inc. (MDT) insulin pump designed to temporarily shut off was able to reduce the incidence of a potentially fatal condition that occurs when blood-sugar levels fall too low–a key advance in the effort to fully automate the delivery of insulin in diabetes patients.
Just launched in the U.S. for the first time on June 4, the MySugr Companion app was created a few years ago by a team of fellow PWDs (and some non-PWDs) over in Austria.
A special type of in vitro fertilization, or IVF, may increase the risk for insulin resistance among children conceived in this way, according to a new study from Greece.
What frequency of self monitoring of blood glucose is considered necessary for the most favorable glycemic control?
A recent study by Dr. Zhen Gu, is part of a growing area of research that seeks to eliminate this balancing act by developing a glucose responsive insulin (GRI). Dr. Gu’s study specifically tested a nanoparticle-based GRI that is injected into the body and releases insulin in response to blood-glucose fluctuations.
A study of older adults with diabetes mellitus (DM) suggests a bidirectional association between hypoglycemic (low blood glucose) events and dementia, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Starting next month Medicare patients with diabetes who receive their diabetes testing supplies via mail order may or may not notice any changes, but after negotiating prices down, CMS is set to start paying the mail order diabetes supply companies about 20 cents per strip beginning July 1.
All of us in the Diabetes Community often wonder: What might the future of insulin look like, and how far out is the exciting new stuff we’re hearing about?
Wil explores another aspect of this BG-lowering elixir as it works (or doesn’t) in people with diabetes (PWDs): insulin resistance, and whether you can be living with two types of diabetes at the same time.
The CVS Mobile app from CVS/pharmacy is a unique new interactive smartphone app that provides users with numerous personalized ways to both manage their healthcare and handle drugstore needs.
mySugr Companion, the Austria-based startup that helps diabetes sufferers manage their condition, has launched its app in the US, as well as adding tech advisor Tim Ferriss to the company’s roster
Obese teenagers who reduced their body mass index (BMI) by 8 percent or more had improvements in insulin sensitivity, an important metabolic factor related to the later development of type 2 diabetes.
Based on his latest study, both the Food and Drug Administration and the European Medicines Agency have begun investigations that could lead to new warnings on the drugs, or even to their removal from the market.
The artificial sweetener may be doing more than making things taste good. New study probes how it effects metabolism and whether raised insulin levels could lead to consumers developing insulin resistance, which may eventually lead to type II diabetes
While media reports have been quick to label this a breakthrough in the study of treatments for type 2 diabetes, its value to T1D research has yet to be determined.
Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar.
Clinicians caring for hospitalized patients must keep the harms of hypoglycemia in mind when managing hyperglycemia and should avoid aggressive glucose management
With so many options available, how do you choose which glucose meter to use?